ARCT

#2959
Arcturus Therapeutics Holdings Inc. Common Stock
8.23
-0.84%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
8.23
8.23
Yıllık aralık
5.86
24.14
Günlük değişim
-0.84%
Aylık değişim
+9.73%
6 aylık değişim
-51.87%
Yıllık değişim
-48.50%
Önceki kapanış
8.30
Open
8.23
Bid
Ask
Low
8.23
High
8.23
Hacim
80
Open full chart

Financials

Overview Rapor Statistics Dividends
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics Holdings Inc. is an American RNA medicines biotechnology company focused on the discovery, development and commercialization of therapeutics for rare diseases and infectious diseases. Arcturus has developed proprietary lipid nanoparticle RNA therapeutics for nucleic acid medicines including small interfering RNA, messenger RNA, gene editing RNA, DNA, antisense oligonucleotides, and microRNA. The company develops RNA therapeutics for the treatment of rare diseases such as ornithine transcarbamylase deficiency, and respiratory diseases such as cystic fibrosis. Vaccine medicines include a vaccine candidate for COVID-19 and an influenza vaccine in the preclinical development phase. The vaccine for COVID-19 was authorised in Japan in 2023 and the European Union in 2025.

Haberler